Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
about
Aortic stenosis: An updateRosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosisCellular mechanisms of aortic valve calcificationIncreased dietary intake of vitamin A promotes aortic valve calcification in vivoCalcific aortic valve disease: is it another face of atherosclerosis?In vitro models of aortic valve calcification: solidifying a systemC-reactive protein in aortic valve diseaseC-reactive protein in degenerative aortic valve stenosisNotch1 represses osteogenic pathways in aortic valve cellsWnt signaling in heart valve development and osteogenic gene inductionPathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Calcific aortic valve stenosis: methods, models, and mechanismsIntegrated microRNA and messenger RNA analysis in aortic stenosis.Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul StudyACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosisBicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.Animal models of calcific aortic valve diseaseThe long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genesInteraction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis.The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/- /Lrp5-/- mice.Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease.Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice.Secreted Wnt modulators in symptomatic aortic stenosisDiseases of Wnt signaling.Shared gene expression profiles in developing heart valves and osteoblast progenitor cellsCalcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic ApproachesThe 'valvulo-metabolic' risk in calcific aortic valve disease.Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.Expression of NPP1 is regulated during atheromatous plaque calcification.Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.Calcific aortic stenosis: lessons learned from experimental and clinical studies.Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans.Heart valve development: regulatory networks in development and disease
P2860
Q24569646-CF674FCB-9C38-4E63-A8A6-75A93274454AQ24595023-48BFE4DF-7018-484A-AEBE-0656A5F9A1F6Q24613042-A4E76646-E436-4A9E-9265-F37893B45393Q24630155-E5B61FD2-2618-447E-BE68-23AD1E1B1C47Q26782519-C232A5DF-6BE4-4DA8-BC4A-919CA17281ADQ27022156-42EF9671-B953-48E9-8831-3C3E1CCF2724Q28200692-78F87C44-C551-4D22-AFDF-A4D86470EA93Q28219092-F69FF7EE-61A6-4FC6-8809-80A79CDCF78EQ28505877-30A883D7-1FCB-4B4D-A7AD-81A6AE11E1DAQ28586329-126CCEDA-C675-408A-B94B-09ED1547A163Q30234828-130CB017-8266-4BA4-8595-9B470EB72804Q30474772-572B108C-F098-46F9-ADB9-8E6FD869D3A0Q30503246-2FDC43EB-55CA-4C68-A8BC-1FEEB50FEF54Q30829479-7378D7FB-0815-4A63-970B-0AE0385107FEQ31111874-2451E0E7-465B-449B-B34F-22676AF01DE9Q33414426-089EC280-5662-4ACA-A92D-5B2774946ED7Q33589249-E7D18587-470E-4F29-A745-147D740B2702Q33765102-EACF0E1B-2027-4736-8E34-CA5AB25CDB57Q34353340-60A71DE8-500D-4A32-B32F-A3C014984151Q34357901-85E7002D-418C-4C77-8149-E8411F64A6E3Q34900192-0071C02E-7CE3-40C9-A956-056387C74238Q35078393-237ED5DA-B701-4C0B-8579-6AA4360A8E32Q35147157-C088141F-236F-4BE0-8374-63E41131FA92Q35161520-11C02D76-43DF-431C-95C1-F7D8ABC595CDQ35635352-7BA94602-377C-4999-B37C-1703218B9802Q35686702-685B2677-3306-4CF2-ADB7-D4EFEA5147A9Q35686707-665760F9-533F-46C4-85E7-6FFADEDEE8C9Q35836894-412475E6-A895-4681-998D-0FC3DC03F9FDQ35914664-DF3EB6C7-EC10-4DF1-A10C-34AC24871EB0Q36519744-62E7E2C7-9E99-4048-941F-93A6C795BCB4Q36582366-8EFA711A-79FE-4ADD-8F74-F261BAE236CAQ36877544-E27FF79B-3603-4833-ACAD-439DAE399B0EQ36956234-188D5A6F-04B8-4BDA-B31D-204C56B0E741Q36969071-834A5AC7-E906-47E1-AA56-B516D6B0AE6EQ37000195-14425ABB-6E79-4A2A-B12B-D30F8C654163Q37294492-9D6EE91C-8B97-44CE-BDDE-B6FA7BD4A73DQ37309166-67A30434-BC90-4688-9361-00B9BE345C12Q37331207-1AAC4255-D83D-4B4A-8675-1F5D0CF86EAFQ37357272-24B39B96-50F7-42FE-8596-AD44670DEA2EQ37421779-31339EE8-A34E-49BA-925A-A02F5D5A0901
P2860
Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@en
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@nl
type
label
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@en
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@nl
prefLabel
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@en
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@nl
P2093
P2860
P1433
P1476
Atorvastatin inhibits hypercho ...... via the Lrp5 receptor pathway.
@en
P2093
Frank Caira
Malayannan Subramaniam
Nalini M Rajamannan
Stuart R Stock
Thomas C Spelsberg
P2860
P304
P356
10.1161/01.CIRCULATIONAHA.104.524306
P407
P433
P577
2005-08-01T00:00:00Z